Price Robert, Poursaid Azadeh, Ghandehari Hamidreza
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT, USA; Utah Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, UT, USA.
Utah Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, UT, USA; Department of Bioengineering, University of Utah, Salt Lake City, UT, USA.
J Control Release. 2014 Sep 28;190:304-13. doi: 10.1016/j.jconrel.2014.06.016. Epub 2014 Jun 21.
Recombinant polymers provide a high degree of molecular definition for correlating structure with function in controlled release. The wide array of amino acids available as building blocks for these materials lend many advantages including biorecognition, biodegradability, potential biocompatibility, and control over mechanical properties among other attributes. Genetic engineering and DNA manipulation techniques enable the optimization of structure for precise control over spatial and temporal release. Unlike the majority of chemical synthetic strategies used, recombinant DNA technology has allowed for the production of monodisperse polymers with specifically defined sequences. Several classes of recombinant polymers have been used for controlled drug delivery. These include, but are not limited to, elastin-like, silk-like, and silk-elastinlike proteins, as well as emerging cationic polymers for gene delivery. In this article, progress and prospects of recombinant polymers used in controlled release will be reviewed.
重组聚合物为在控释中将结构与功能相关联提供了高度的分子定义。作为这些材料构建单元的多种氨基酸赋予了许多优势,包括生物识别、生物降解性、潜在的生物相容性以及对机械性能等其他特性的控制。基因工程和DNA操作技术能够优化结构,以精确控制空间和时间释放。与大多数化学合成策略不同,重组DNA技术使得能够生产具有特定定义序列的单分散聚合物。几类重组聚合物已被用于控释给药。这些包括但不限于类弹性蛋白、类丝蛋白和丝弹性蛋白样蛋白,以及用于基因递送的新兴阳离子聚合物。在本文中,将对用于控释的重组聚合物的进展和前景进行综述。